E-LIB Suche - Ergebnisse für: Apolo, A. B.

1

Nivolumab plus cabozantinib versus sunitinib for first-line..:

Powles, T. ; Burotto, M. ; Escudier, B....
ESMO Open. 9 (2024) 5 - p. 102994 , 2024

Link: https://doi.org/10.1016/..

2

Upper tract urothelial carcinoma topical issue 2016: treatm..:

Pham, M. N. ; Apolo, A. B. ; De Santis, M....
World Journal of Urology. 35 (2016) 3 - p. 367-378 , 2016

Link: https://doi.org/10.1007/..

3

2630 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in pat..:

Apolo, A.B. ; Infante, J.R. ; Hamid, O....
European Journal of Cancer. 51 (2015) - p. S522 , 2015

Link: https://doi.org/10.1016/..

4

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of..:

Cowan, N. G. ; Chen, Y. ; Downs, T. M....
Advances in Urology. 2014 (2014) - p. 1-6 , 2014

Link: https://doi.org/10.1155/..

5

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerabi..:

Amara, Chandra Sekhar ; Kami Reddy, Karthik Reddy ; Yuntao, Yang...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Mismatch repair deficiency and microsatellite instability i..:

Chandran, Elias B A ; Iannantuono, Giovanni Maria ; Atiq, Saad O...
BMJ Oncology. 3 (2024) 1 - p. e000335 , 2024

Link: https://doi.org/10.1136/..

7

Ensuring Successful Biomarker Studies in Bladder Preservati..:

McConkey, David J. ; Baumann, Brian C. ; Cooper Greenberg, Stephanie...
Bladder Cancer. 10 (2024) 1 - p. 1-8 , 2024

Link: https://doi.org/10.3233/..

8

The value of IMmotion010 for rare kidney cancer histologies:

Iannantuono, Giovanni Maria ; Chandran, Elias ; Apolo, Andrea B
The Lancet. 402 (2023) 10397 - p. 181 , 2023

Link: https://doi.org/10.1016/..

9

Urinary Neuroendocrine Neoplasms Treated in the "Modern Era..:

Le, Bryan Khuong ; McGarrah, Patrick ; Paciorek, Alan...
Clinical Genitourinary Cancer. 21 (2023) 3 - p. 403-414.e5 , 2023

Link: https://doi.org/10.1016/..

10

Systemic therapy issues: Immunotherapy in nonmetastatic uro..:

Nadal, Rosa ; Apolo, Andrea B. ; Girardi, Daniel M...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 1 - p. 27-34 , 2023

Link: https://doi.org/10.1016/..

11

Clinically oriented prediction of patient response to targe..:

Dinstag, Gal ; Shulman, Eldad D. ; Elis, Efrat...
Med. 4 (2023) 1 - p. 15-30.e8 , 2023

Link: https://doi.org/10.1016/..

12

Systemic therapy in bladder preservation:

Girardi, Daniel M. ; Ghatalia, Pooja ; Singh, Parminder...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 1 - p. 39-47 , 2023

Link: https://doi.org/10.1016/..

13

Cabozantinib for the treatment of solid tumors: a systemati..:

Maroto, Pablo ; Porta, Camillo ; Capdevila, Jaume...
Therapeutic Advances in Medical Oncology. 14 (2022) - p. 175883592211071 , 2022

Link: https://doi.org/10.1177/..

14

Management of adverse events associated with cabozantinib p..:

McGregor, Bradley ; Mortazavi, Amir ; Cordes, Lisa...
Cancer Treatment Reviews. 103 (2022) - p. 102333 , 2022

Link: https://doi.org/10.1016/..

15

Predicting cancer immunotherapy response from gut microbiom..:

Liang, Hai ; Jo, Jay-Hyun ; Zhang, Zhiwei...
Oncotarget. 13 (2022) 1 - p. 876-889 , 2022

Link: https://doi.org/10.18632..